Study to Evaluate the Efficacy of Afatinib in Skull Base Chordoma

Clinical trial NCT05519917 · UNKNOWN

Trial details

NCT number: NCT05519917
Sponsor: Huashan Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chordoma of Clivus

Start date: 2022-10-01
Primary completion: 2025-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.